Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Medicare Sets National Price for KidneyIntelX™

December 3, 2019
NEW YORK, Dec. 3, 2019 /PRNewswire/ --  Renalytix AI plc  (LSE: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that the Centers for Medicare and Medicaid Services ("CMS") has released the Final 2020 Clinical Laboratory Fee Schedule

U.S. CPT® Code Granted for KidneyIntelX™

July 1, 2019
CPT Code a key component for reimbursement from private medical insurance and Medicare   NEW YORK, July 1, 2019 /PRNewswire/ --  Renalytix AI plc  (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that the American Medical
Displaying 81 - 90 of 96